Abstract
Abstract Since 2008, Baclofen’s gamut has gradually evolved from an anti-spastic agent to an off label anti-craving agent in Alcohol Use Disorders. However, with its accreditation in addictions psychiatry, have emerged additional risk of abuse of its relaxant properties. Over the last decade there have been increase in reports of its abuse for recreation or intentional self-harm. A high index of suspicion should be exercised in patients of Alcohol Use Disorders presenting with unexplained features of central nervous system depression. We hereby report a case of alcoholic dependence syndrome who presented in an unconscious state with bradycardia, bradypnea and pin-pointed fixed pupils after ingestion of 200 mg of tablet Baclofen with around 65 grams of alcohol and posed a diagnostic challenge.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
